hotspot -WSS

hotspot

author：explore 2025-09-28 15:06:37 - browse：3

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Investigation reveals sickle cell patients pressured into sterilizations

hotspot

WSS

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Cue Health, Covid

Will Ozempic

Addressing health care workers' trauma can help fight burnout

Studies point to risks of excluding people with obesity from drug trials

focus

hotspot

hotspot

Drug repurposing or repositioning? The language matters

FDA warns J&J's Abiomed: We will regulate your software

ChatGPT in medicine: STAT answers readers' burning questions

Liver decline slowed by off

State Dept. review finds Biden bears some blame for Afghanistan failures

The EU Joint Clinical Assessment needs to live up to its promise

Apple is now the first public company to be valued at $3 trillion

STAT Summit: Biotech founders on deal

Medicare proposal to cover medical devices draws a mixed reaction

Senate committee scrutinizes Medicare Advantage brokers

explore

Questions and answers about ramping up H5N1 bird flu vaccine

Listen: More tumult at BIO & coercive care for sickle cell patients

Bird flu surveillance in wastewater gets boost from consortium

Biogen joins immunology wave with $1.15 billion acquisition of HI

NIH confirmation hearing shows politicization of research

Scrutiny of post

hotspot

focus

entertainment

Wikipedia